Overview
Preemptive Analgesia for Primary Dysmenorrhoea
Status:
Completed
Completed
Trial end date:
2017-12-01
2017-12-01
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
Preemptive analgesia before the release of pain mediatorsPhase:
Phase 2/Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Hanan NabilTreatments:
Mefenamic Acid
Criteria
Inclusion Criteria:- nulliparous ladies
- with regular menstrual cycle pattern
- those experienced history of dysmenorrhea (primary or spasmodic)
- patients able to sallow tables
Exclusion Criteria:
- irregular cycles
- any associated local causes( pelvic infection, endometriosis, fibroid or others)
- patients with familial Mediterranean fever or other intermenstrual attacks of
abdominal pain
- gastric or duodenal ulcers or gastritis
- other contraindications to non steroidal anti-inflammatory drugs
- patients with severe diminution of vision or color discrimination
- patients with any depressive or mood disorders
- patients receiving any hormonal treatment